Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 6766: Assessing the impact of immunotherapies and cell therapies in 3D heterospheroid models mimicking tumor microenvironments

Natasha Helleberg Madsen, Boye Schnack Nielsen, Kim Holmstrøm, Gitte Olofsson, Per thor Straten, Søren Skov, Carlos Rodriguez-Pardo, Maria Ormhøj, Jesper Larsen, Monika Gad

Cancer Res (2024) 84 (6_Supplement): 6766.

https://doi.org/10.1158/1538-7445.AM2024-6766

Published: 22 March 2024

View article titled, Abstract 6766: Assessing the impact of immunotherapies and cell therapies in 3D heterospheroid models mimicking tumor microenvironments

Journal Articles

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Cancer Res (2017) 77 (17): 4562–4566.

https://doi.org/10.1158/0008-5472.CAN-16-3172

Published: 31 August 2017

View article titled, Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Includes: Supplementary data

Journal Articles

Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

Norbert Hilf, Katrin Frenzel, Sabrina Kuttruff-Coqui, Sandra Heesch, Sebastian Kreiter, Arie Admon, Valesca Bukur, Sjoerd van der Burg, Cecile Gouttefangeas, Judith R. Kroep, Marij Schoenmaekers-Welters, Jordi Piro, Berta Ponsati, Hans Skovgaard Poulsen, Ulrik Lassen, Francisco Martinez-Ricarte, Jordi Rodon, Juan Sahuquillo, Monika Stieglbauer, Stefan Stevanovic, Per thor Straten, Marco Skardelly, Ghazaleh Tabatabai, Michael Platten, David Capper, Andreas von Deimling, Valérie Dutoit, Hideho Okada, Christian Ottensmeier, Randi Kristina Feist, Jens Fritsche, Karoline Laske, Peter Lewandrowski, Martin Löwer, Regina Mendryzk, Miriam Meyer, Carsten Reinhardt, Bernhard Rössler, Anna Paruzynski, Nina Pawlowski, Colette Song, Stevermann Lea, Toni Weinschenk, Christoph Huber, Hans-Georg Rammensee, Pierre-Yves Dietrich, Wick Wolfgang, Ugur Sahin, Harpreet Singh-Jasuja

Cancer Res (2016) 76 (14_Supplement): 2654.

https://doi.org/10.1158/1538-7445.AM2016-2654

Published: 15 July 2016

View article titled, Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

Journal Articles

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4⁺ T- Cells, Which Dampen CD8⁺ T-cell Antitumor Reactivity

Marco Donia, Rikke Andersen, Julie W. Kjeldsen, Paolo Fagone, Shamaila Munir, Ferdinando Nicoletti, Mads Hald Andersen, Per thor Straten, Inge Marie Svane

Cancer Res (2015) 75 (18): 3747–3759.

https://doi.org/10.1158/0008-5472.CAN-14-2956

Published: 14 September 2015

View article titled, Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

Includes: Supplementary data

Journal Articles

Dissection of T-cell Antigen Specificity in Human Melanoma

Rikke Sick Andersen, Charlotte Albæk Thrue, Niels Junker, Rikke Lyngaa, Marco Donia, Eva Ellebæk, Inge Marie Svane, Ton N. Schumacher, Per thor Straten, Sine Reker Hadrup

Cancer Res (2012) 72 (7): 1642–1650.

https://doi.org/10.1158/0008-5472.CAN-11-2614

Published: 01 April 2012

View article titled, Dissection of T-cell Antigen Specificity in Human Melanoma

Includes: Supplementary data

Journal Articles

Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2

Rikke Bæk Sørensen, Tania Køllgaard, Rikke Sick Andersen, Joost Huibert van den Berg, Inge Marie Svane, Per thor Straten, Mads Hald Andersen

Cancer Res (2011) 71 (6): 2038–2044.

https://doi.org/10.1158/0008-5472.CAN-10-3403

Published: 14 March 2011

View article titled, Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2

Includes: Supplementary data

Journal Articles

Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B

Søren Skov, Marianne Terndrup Pedersen, Lars Andresen, Per Thor Straten, Anders Woetmann, Niels Ødum

Cancer Res (2005) 65 (23): 11136–11145.

https://doi.org/10.1158/0008-5472.CAN-05-0599

Published: 01 December 2005

View article titled, Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B

Journal Articles

The Paradoxical Association between Bcl-2 Expression and Prognosis: Does the Immune System Make the Difference?

Jürgen C. Becker, Per thor Straten, Mads Hald Andersen

Cancer Res (2005) 65 (7): 2983.

https://doi.org/10.1158/0008-5472.CAN-05-0092

Published: 01 April 2005

View article titled, The Paradoxical Association between Bcl-2 Expression and Prognosis: Does the Immune System Make the Difference?

Journal Articles

Immunogenicity of Constitutively Active ^V599EBRaf

Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, Jürgen C. Becker

Cancer Res (2004) 64 (15): 5456–5460.

https://doi.org/10.1158/0008-5472.CAN-04-0937

Published: 02 August 2004

View article titled, Immunogenicity of Constitutively Active V599EBRaf

Journal Articles

Identical T-cell Receptor Transcripts in Multiple Melanoma Metastases

David Schrama, Eva Fuchs, Eva-Bettina Bröcker, Per thor Straten, Jürgen C. Becker

Cancer Res (2002) 62 (20): 5664–5667.

Published: 15 October 2002

View article titled, Identical T-cell Receptor Transcripts in Multiple Melanoma Metastases

Journal Articles

Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients

Mads Hald Andersen, Lars Ø. Pedersen, Barbara Capeller, Eva-Bettina Bröcker, Jürgen C. Becker, Per thor Straten

Cancer Res (2001) 61 (16): 5964–5968.

Published: 01 August 2001

View article titled, Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients

Journal Articles

Identification of a Cytotoxic T Lymphocyte Response to the Apoptosis Inhibitor Protein Survivin in Cancer Patients

Mads Hald Andersen, Lars Østergaard Pedersen, Jürgen C. Becker, Per thor Straten

Cancer Res (2001) 61 (3): 869–872.

Published: 02 February 2001

View article titled, Identification of a Cytotoxic T Lymphocyte Response to the Apoptosis Inhibitor Protein Survivin in Cancer Patients

Journal Articles

Oligoclonal T-Cell Receptor Usage of Melanocyte Differentiation Antigen-reactive T Cells in Stage IV Melanoma Patients

David Schrama, Mads Hald Andersen, Patrick Terheyden, Louise Schrøder, Lars Østergaard Pedersen, Per thor Straten, Jürgen C. Becker

Cancer Res (2001) 61 (2): 493–496.

Published: 01 January 2001

View article titled, Oligoclonal T-Cell Receptor Usage of Melanocyte Differentiation Antigen-reactive T Cells in Stage IV Melanoma Patients

Journal Articles

Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma

Per Guldberg, Per thor Straten, Anette Birck, Vibeke Ahrenkiel, Alexei F. Kirkin, Jesper Zeuthen

Cancer Res (1997) 57 (17): 3660–3663.

Published: 01 September 1997

View article titled, Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma

NARROW

Abstract 6766: Assessing the impact of immunotherapies and cell therapies in 3D heterospheroid models mimicking tumor microenvironments

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4⁺ T- Cells, Which Dampen CD8⁺ T-cell Antitumor Reactivity

Dissection of T-cell Antigen Specificity in Human Melanoma

Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2

Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B

The Paradoxical Association between Bcl-2 Expression and Prognosis: Does the Immune System Make the Difference?

Immunogenicity of Constitutively Active ^V599EBRaf

Identical T-cell Receptor Transcripts in Multiple Melanoma Metastases

Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients

Identification of a Cytotoxic T Lymphocyte Response to the Apoptosis Inhibitor Protein Survivin in Cancer Patients

Oligoclonal T-Cell Receptor Usage of Melanocyte Differentiation Antigen-reactive T Cells in Stage IV Melanoma Patients

Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only